Sign Up Today and Learn More About Aspen Neuroscience Stock
Invest in or calculate the value of your shares in Aspen Neuroscience or other pre-IPO companies through EquityZen's platform.
Aspen Neuroscience Stock (ASNE)
Aspen Neuroscience is a biotechnology company that uses innovative genomic approaches combined with stem cell biology.
About Aspen Neuroscience Stock
Founded
2018
Headquarters
San Diego, CA, US
Industries
Software, Artificial Intelligence, Data and Analytics
Aspen Neuroscience is a development stage and private biotechnology company that uses innovative genomic approaches combined with stem cell biology to deliver patient-specific, restorative cell therapies that modify the course of Parkinson's disease. It develops enabling technologies for patient-specific induced pluripotent stem cell-based therapies.
Aspen Neuroscience Press Mentions
Stay in the know about the latest news on Aspen Neuroscience
Aspen Neuroscience to Present at the International Society for Stem Cell Research (ISSCR) 2025 Annual Meeting
prnewswire • Jun 09, 2025
Aspen Neuroscience to Present at American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
prnewswire • May 17, 2025
Aspen Neuroscience to Present at American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
biospace • May 17, 2025
Aspen Neuroscience to Present at American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
morningstar • May 17, 2025
Aspen Neuroscience Announces 6-Month ASPIRO Phase 1/2a Clinical Trial Results of Personalized Cell Therapy for Parkinson’s Disease
sdbn • May 08, 2025
Aspen Neuroscience Management
Leadership team at Aspen Neuroscience
Co-Founder & Chief Scientific Officer
Jeanne Loring
Board Member, Seed Investor
Drew Spaventa
Join now and verify your accreditation status to gain access to:
- Aspen Neuroscience Current Valuation
- Aspen Neuroscience Stock Price
- Aspen Neuroscience Management
- Available deals in Aspen Neuroscience and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Aspen Neuroscience Cap Table and Funding History by Share Class and Liquidity Preferences
- Aspen Neuroscience Revenue and Financials
- Aspen Neuroscience Highlights
- Aspen Neuroscience Business Model
- Aspen Neuroscience Risk Factors
- Aspen Neuroscience Research Report from SACRA Research
Trading Aspen Neuroscience Stock
How to invest in Aspen Neuroscience stock?
Accredited investors can buy pre-IPO stock in companies like Aspen Neuroscience through EquityZen funds. These investments are made available by existing Aspen Neuroscience shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Aspen Neuroscience stock?
Shareholders can sell their Aspen Neuroscience stock through EquityZen's private company marketplace. EquityZen's network includes over 370K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
